 
 
EXPLANATION:  CAPITALS INDICATE MAT TER ADDED TO EXISTIN G LAW . 
        [Brackets ] indicate matter deleted from existing law.  
         Underlining  indicates amendments to bill.  
         Strike out  indicates matter stricken from the bill by amendment or deleted from the law by 
amendment.             *sb0459*      
SENATE BILL 459  
J1, J2, F5    5lr3037  
    CF HB 420  
By: Senator Gile  
Introduced and read first time: January 21, 2025  
Assigned to: Finance and Education, Energy,  and the Environment  
Committee Report: Favorable  
Senate action: Adopted  
Read second time: February 11, 2025  
 
CHAPTER ______  
 
AN ACT concerning  1 
 
Education and Health – Emergency Use Epinephrine – Alterations  2 
 
FOR the purpose of altering the defined term “auto –injectable epinephrine” to be 3 
“emergency use epinephrine” and to include certain drug delivery devices and 4 
products; altering the name of the Emergency Use Auto –Injectable Epinephrine 5 
Program to be the Emergency Use Epinephrine Program; and gene rally relating to 6 
emergency use epinephrine.  7 
 
BY repealing and reenacting, with amendments,  8 
 Article – Education  9 
Section 7 –426.2, 7 –426.3, and 9.5 –117(a)(3) and (f)  10 
 Annotated Code of Maryland  11 
 (2022 Replacement Volume and 2024 Supplement)  12 
 
BY repealing and reenacting, without amendments,  13 
 Article – Education  14 
Section 9.5 –117(a)(1)  15 
 Annotated Code of Maryland  16 
 (2022 Replacement Volume and 2024 Supplement)  17 
 
BY repealing and reenacting, with amendments,  18 
 Article – Health – General  19 
Section 13 –702, 13 –704(e), 13 –705, 13 –706(a), 13 –707(a) and (b), and 13 –708(b); and 20 
13–7A–01, 13 –7A–02, 13 –7A–03(a)(5), 13 –7A–06, 13 –7A–07(a) and (b),  21 
2 SENATE BILL 459   
 
 13–7A–08(b), and 13 –7A–09 to be under the amended subtitle “Subtitle 7A. 1 
Emergency Use Epinephrine Progr am” 2 
 Annotated Code of Maryland  3 
 (2023 Replacement Volume and 2024 Supplement)  4 
 
BY repealing and reenacting, without amendments,  5 
 Article – Health Occupations  6 
Section 14 –5F–01(a) and 14 –5F–04.1(a)(1)  7 
 Annotated Code of Maryland  8 
 (2021 Replacement Volume an d 2024 Supplement)  9 
 
BY repealing  10 
 Article – Health Occupations  11 
Section 14 –5F–01(c)  12 
 Annotated Code of Maryland  13 
 (2021 Replacement Volume and 2024 Supplement)  14 
 
BY repealing and reenacting, with amendments,  15 
 Article – Health Occupations  16 
Section 14 –5F–01(d) t hrough (g), 14 –5F–04.1(d)(1), and 14 –5F–14(a)(5)  17 
 Annotated Code of Maryland  18 
 (2021 Replacement Volume and 2024 Supplement)  19 
 
BY adding to  20 
 Article – Health Occupations  21 
Section 14 –5F–01(g)  22 
 Annotated Code of Maryland  23 
 (2021 Replacement Volume and 2024 Supplement)  24 
 
 SECTION 1. BE IT ENACTED BY THE GENERAL ASSEMBLY OF MARYLAND, 25 
That the Laws of Maryland read as follows:  26 
 
Article – Education  27 
 
7–426.2.  28 
 
 (a) (1) In this section the following words have the meanings indicated.  29 
 
  (2) “Anaphylaxis” means a su dden, severe, and potentially life –threatening 30 
allergic reaction that occurs when an individual is exposed to an allergen.  31 
 
  (3) [“Auto –injectable ] “EMERGENCY USE  epinephrine” means a portable, 32 
disposable drug delivery device OR PRODUCT  APPROVED BY THE FEDERAL FOOD AND 33 
DRUG ADMINISTRATION that contains a premeasured single dose of epinephrine that is 34 
used to treat anaphylaxis in an emergency situation.  35 
 
 SENATE BILL 459  3 
 
  (b) Each county board shall establish a policy for public schools within its 1 
jurisdiction to authoriz e the school nurse and other school personnel to administer  2 
[auto–injectable ] EMERGENCY USE  epinephrine, if available, to a student who is 3 
determined to be or perceived to be in anaphylaxis, regardless of whether the student:  4 
 
  (1) Has been identified as  having an anaphylactic allergy, as defined in § 5 
7–426.1 of this subtitle; or  6 
 
  (2) Has a prescription for epinephrine as prescribed by an authorized 7 
licensed health care practitioner under the Health Occupations Article.  8 
 
 (c) The policy established unde r subsection (b) of this section shall include:  9 
 
  (1) Training for school personnel on how to recognize the symptoms of 10 
anaphylaxis;  11 
 
  (2) Procedures for the emergency administration of [auto–injectable ] 12 
EMERGENCY USE  epinephrine;  13 
 
  (3) The proper follow –up emergency procedures;  14 
 
  (4) A provision authorizing a school nurse to obtain and store at a public 15 
school [auto–injectable ] EMERGENCY USE  epinephrine to be used in an emergency 16 
situation; and  17 
 
  (5) A requirement that each public school develop and implement a method 18 
for notifying the parents or guardians of students of the school’s policy under this section 19 
at the beginning of each school year.  20 
 
 (d) Except for any willful or grossly negligent act, a school nurse or other school 21 
personnel who re spond in good faith to the anaphylactic reaction of a child in accordance 22 
with this section may not be held personally liable for any act or omission in the course of 23 
responding to the reaction.  24 
 
 (e) (1) Each public school shall submit, on the form that t he Department 25 
requires, a report to the Department on each incident at the school or at a related school 26 
event that required the use of [auto–injectable ] EMERGENCY USE  epinephrine.  27 
 
  (2) The Department shall develop and disseminate a standard form to 28 
report each incident requiring the use of [auto–injectable ] EMERGENCY USE  epinephrine 29 
at a public school.  30 
 
7–426.3.  31 
 
 (a) (1) In this section the following words have the meanings indicated.  32 
 
4 SENATE BILL 459   
 
   (2) “Anaphylaxis” means a sudden, severe, and potentially life –threatening 1 
allergic reaction that occurs when an individual is exposed to an allergen.  2 
 
  (3) [“Auto –injectable ] “EMERGENCY USE  epinephrine” means a portable, 3 
disposable drug delivery device OR PRODUCT  APPROVED BY THE FEDE RAL FOOD AND 4 
DRUG ADMINISTRATION that contains a premeasured single dose of epinephrine that is 5 
used to treat anaphylaxis in an emergency situation.  6 
 
  (4) “School personnel” means individuals who are employed by a nonpublic 7 
school, including part –time employees, teachers and substitute teac hers employed by the 8 
school for at least 7 days each school year, a school nurse, registered nurse case manager, 9 
delegating nurse, and administrative staff.  10 
 
 (b) Each nonpublic school in the State may establish a policy authorizing school 11 
personnel to adm inister [auto–injectable ] EMERGENCY USE  epinephrine, if available, to a 12 
student who is determined to be or perceived to be in anaphylaxis, regardless of whether 13 
the student:  14 
 
  (1) Has been identified as having an anaphylactic allergy, as defined in § 15 
7–426.1 of this subtitle; or  16 
 
  (2) Has a prescription for epinephrine as prescribed by an authorized 17 
licensed health care practitioner under the Health Occupations Article.  18 
 
 (c) The policy established under subsection (b) of this section shall include:  19 
 
  (1) Training for school personnel on how to recognize the signs and 20 
symptoms of anaphylaxis by a licensed health care practitioner who is authorized to 21 
administer [auto–injectable ] EMERGENCY USE  epinephrine and who has been trained in 22 
an established protoc ol on how to recognize the signs and symptoms of anaphylaxis;  23 
 
  (2) Procedures for the emergency administration of [auto–injectable ] 24 
EMERGENCY USE  epinephrine;  25 
 
  (3) The proper follow –up emergency procedures;  26 
 
  (4) A provision authorizing a school nurse  or other licensed health care 27 
practitioner to obtain , and[,] school personnel to store, at a nonpublic school  28 
[auto–injectable ] EMERGENCY USE  epinephrine to be used in an emergency situation;  29 
 
  (5) A requirement that the nonpublic school develop and implement a 30 
method for notifying the parents or guardians of students of the school’s policy under this 31 
section at the beginning of each school year; and  32 
 
 SENATE BILL 459  5 
 
   (6) An ongoing process for oversight and monitoring by a licensed health 1 
care practitioner of the i mplementation of the policy established under subsection (b) of this 2 
section.  3 
 
 (d) Except for any willful or grossly negligent act, school personnel who respond 4 
in good faith to the anaphylactic reaction of a child in accordance with this section may not 5 
be held personally liable for any act or omission in the course of responding to the reaction.  6 
 
9.5–117. 7 
 
 (a) (1) In this section the following words have the meanings indicated.  8 
 
  (3) [“Auto –injectable ] “EMERGENCY USE  epinephrine” has the meaning 9 
stated  in § 7 –426.2 of this article.  10 
 
 (f) Except for any willfully or grossly negligent act, a child care provider or an 11 
employee of a child care provider who responds in good faith to the anaphylactic reaction 12 
of a child in accordance with the guidelines imple mented under this section or by use of 13 
[auto–injectable ] EMERGENCY USE  epinephrine is immune from civil liability for any act 14 
or omission in the course of responding to the reaction.  15 
 
Article – Health – General  16 
 
13–702. 17 
 
 (a) In this subtitle the following  words have the meanings indicated.  18 
 
 (b) “Agent” means an individual who:  19 
 
  (1) Is at least 18 years of age;  20 
 
  (2) Has successfully completed, at the expense of an applicant, an 21 
educational training program approved by the Department; and  22 
 
  (3) Is appo inted by a certificate holder to administer [auto–injectable ] 23 
EMERGENCY USE  epinephrine in accordance with the provisions of this subtitle.  24 
 
 (c) “Anaphylaxis” means a sudden, severe, and potentially life –threatening 25 
allergic reaction that occurs when an i ndividual is exposed to an allergen.  26 
 
 [(d) “Auto –injectable  epinephrine” means a portable, disposable drug delivery 27 
device that contains a premeasured single dose of epinephrine that is used to treat 28 
anaphylaxis in an emergency situation. ] 29 
 
 [(e)] (D) “Certificate” means a certificate or an endorsement on the operating 30 
certificate of a youth camp issued by the Department to an individual who operates a youth 31 
6 SENATE BILL 459   
 
 camp under Title 14, Subtitle 4 of this article to obtain, store, and administer  1 
[auto–injectable ] EMERGENCY USE  epinephrine.  2 
 
 [(f)] (E) “Certificate holder” means an individual who is authorized by the 3 
Department to obtain, store, and administer [auto–injectable ] EMERGENCY USE  4 
epinephrine to be used in an emergency situation.  5 
 
 (F) “EMERGENCY USE EPI NEPHRINE ” MEANS A PORTABLE , DISPOSABLE 6 
DRUG DELIVERY DEVICE  OR PRODUCT APPROVED BY THE FEDERAL FOOD AND 7 
DRUG ADMINISTRATION THAT C ONTAINS A PREMEASURE D SINGLE DOSE OF 8 
EPINEPHRINE THAT IS USED TO TREAT ANAPHY LAXIS IN AN EMERGENC Y SITUATION . 9 
 
 (g) “Program” means the Emergency and Allergy Treatment Program.  10 
 
 (h) “Registered nurse practitioner” has the meaning stated in § 8 –101 of the 11 
Health Occupations Article.  12 
 
 (i) “Youth camp” has the meaning stated in § 14 –401 of this article.  13 
 
13–704. 14 
 
 (e) An applicant  shall have a written policy that includes:  15 
 
  (1) Authorization for the certificate holder or agent to administer  16 
[auto–injectable ] EMERGENCY USE  epinephrine, if available, to an individual who has 17 
been determined to be or is believed to be experiencing anaphylaxis, whether or not the 18 
individual:  19 
 
   (i) Has previously been known to have experienced anaphylaxis; or  20 
 
   (ii) Has a prescription for epinephrine prescribed by an authorized 21 
health care practitioner licensed under the Health Occupations Article ; 22 
 
  (2) A requirement that youth camp personnel complete training on how to 23 
recognize the symptoms of anaphylaxis;  24 
 
  (3) Procedures for the emergency administration of [auto–injectable ] 25 
EMERGENCY USE  epinephrine;  26 
 
  (4) Procedures for proper emergency fo llow–up; 27 
 
  (5) Authorization for a certificate holder to obtain and store  28 
[auto–injectable ] EMERGENCY USE  epinephrine to be used in an emergency; and  29 
 
 SENATE BILL 459  7 
 
   (6) A requirement that each certificate holder implement a method for 1 
notifying the parent or guardia n of a camper of the youth camp’s policy under this section 2 
before the camper’s attendance.  3 
 
13–705. 4 
 
 (a) (1) A registered nurse practitioner or a physician licensed to practice 5 
medicine in the State may prescribe [auto–injectable ] EMERGENCY USE  epinephrine in 6 
the name of a certificate holder.  7 
 
  (2) A registered nurse practitioner, a pharmacist licensed to practice 8 
pharmacy in the State, or a physician may dispense [auto–injectable ] EMERGENCY USE  9 
epinephrine under a prescription issued to a certificate holder.  10 
 
 (b) A certificate holder may:  11 
 
  (1) On presentment of a certificate, receive from any registered nurse 12 
practitioner or any physician licensed to practice medicine in the State a prescript ion for 13 
[auto–injectable ] EMERGENCY USE  epinephrine and the necessary paraphernalia for the 14 
administration of [auto–injectable ] EMERGENCY USE  epinephrine; and  15 
 
  (2) Possess and store prescribed [auto–injectable ] EMERGENCY USE  16 
epinephrine and the necessary  paraphernalia for the administration of [auto–injectable ] 17 
EMERGENCY USE  epinephrine.  18 
 
 (c) In an emergency situation when registered nurse practitioner, physician, or 19 
emergency medical services are not immediately available, a certificate holder or agent may 20 
administer [auto–injectable ] EMERGENCY USE  epinephrine to an individual who is 21 
experiencing or believed in good faith by the certificate holder or agent to be experiencing 22 
anaphylaxis.  23 
 
13–706. 24 
 
 (a) A certificate holder shall submit to the Department,  on a form required by the 25 
Department, a report of each incident that occurs while the youth camp is in session that 26 
required the administration of [auto–injectable ] EMERGENCY USE  epinephrine.  27 
 
13–707. 28 
 
 (a) A cause of action may not arise against a certif icate holder or agent authorized 29 
under this subtitle for any act or omission when the certificate holder or agent is acting in 30 
good faith while administering [auto–injectable ] EMERGENCY USE  epinephrine to an 31 
individual experiencing or believed by the certi ficate holder or agent to be experiencing 32 
anaphylaxis, except where the conduct of the certificate holder or agent amounts to gross 33 
negligence, willful or wanton misconduct, or intentionally tortious conduct.  34 
 
8 SENATE BILL 459   
 
  (b) (1) A cause of action may not arise again st any physician for any act or 1 
omission when the physician in good faith prescribes or dispenses [auto–injectable ] 2 
EMERGENCY USE  epinephrine and the necessary paraphernalia for the administration of 3 
[auto–injectable ] EMERGENCY USE  epinephrine to a person certified by the Department 4 
under this subtitle.  5 
 
  (2) A cause of action may not arise against any pharmacist for any act or 6 
omission when the pharmacist in good faith dispenses [auto–injectable ] EMERGENCY USE  7 
epinephrine and the necessary paraphernalia f or the administration of [auto–injectable ] 8 
EMERGENCY USE  epinephrine to a person certified by the Department under this subtitle.  9 
 
  (3) A cause of action may not arise against any nurse practitioner for any 10 
act or omission when the nurse practitioner in g ood faith prescribes or dispenses  11 
[auto–injectable ] EMERGENCY USE  epinephrine and the necessary paraphernalia for the 12 
administration of [auto–injectable ] EMERGENCY USE  epinephrine to a person certified by 13 
the Department under this subtitle.  14 
 
13–708. 15 
 
 (b) An individual may not be held civilly liable in any action arising from or in 16 
connection with the administration of [auto–injectable ] EMERGENCY USE  epinephrine by 17 
the individual solely because the individual did not possess a certificate issued under this  18 
subtitle.  19 
 
Subtitle 7A. Emergency Use  [Auto –Injectable ] Epinephrine Program.  20 
 
13–7A–01. 21 
 
 (a) In this subtitle the following words have the meanings indicated.  22 
 
 (b) “Agent” means an individual who:  23 
 
  (1) Is at least 18 years of age;  24 
 
  (2) Has successfully completed, at the expense of the participating facility, 25 
an educational training program approved by the Department under § 13 –7A–03 of this 26 
subtitle; and  27 
 
  (3) Is designated by a certificate holder to administer [auto–injectable ] 28 
EMERGENCY U SE epinephrine in accordance with the provisions of this subtitle.  29 
 
 (c) “Anaphylaxis” means a sudden, severe, and potentially life –threatening 30 
allergic reaction that occurs when an individual is exposed to an allergen.  31 
 
 SENATE BILL 459  9 
 
  [(d) “Auto –injectable epinephrine”  means a portable, disposable drug delivery 1 
device that contains a premeasured single dose of epinephrine that is used to treat 2 
anaphylaxis in an emergency situation. ] 3 
 
 [(e)] (D) “Certificate” means a certificate issued by the Department to an 4 
individual to obtain, store, and administer [auto–injectable ] EMERGENCY USE  5 
epinephrine.  6 
 
 [(f)] (E) “Certificate holder” means an individual who is authorized by the 7 
Department to obtain, store, and administer [auto–injectable ] EMERGENCY USE  8 
epinephrine to be used i n an emergency situation.  9 
 
 [(g)] (F) “Eligible institution” means an institution of higher education that has 10 
a food service facility or a recreation and wellness facility on the premises and that is 11 
authorized under this subtitle to obtain and store [auto–injectable ] EMERGENCY USE  12 
epinephrine.  13 
 
 (G) “EMERGENCY USE EPINEPH RINE” MEANS A PORTABLE , DISPOSABLE 14 
DRUG DELIVERY DEVICE  OR PRODUCT APPROVED BY THE FEDERAL FOOD AND 15 
DRUG ADMINISTRATION THAT C ONTAINS A PREMEASURE D SINGLE DOSE OF 16 
EPINEPHRINE THAT IS USED  TO TREAT ANAPHYLAXIS  IN AN EMERGENCY SITU ATION . 17 
 
 (h) “Food service facility” has the meaning indicated in § 21 –301 of this article.  18 
 
 (i) “Participating facility” means a recreation or wellness facility at an eligible 19 
institution or a food service facili ty, including a food service facility at an eligible 20 
institution, in the State that voluntarily participates in the Program.  21 
 
 (j) “Program” means the Emergency Use [Auto –Injectable ] Epinephrine 22 
Program established under § 13 –7A–02 of this subtitle.  23 
 
13–7A–02. 24 
 
 (a) There is an Emergency Use [Auto –Injectable ] Epinephrine Program.  25 
 
 (b) The purpose of the Program is to authorize individuals employed by a 26 
participating facility to obtain and store [auto–injectable ] EMERGENCY USE  epinephrine 27 
and administer [auto–injectable ] EMERGENCY USE  epinephrine to individuals who are 28 
experiencing or are believed to be experiencing anaphylaxis when a physician or emergency 29 
medical services are not immediately available.  30 
 
 (c) (1) Subject to paragraph (4) of this subsection,  each participating facility 31 
may obtain:  32 
 
10 SENATE BILL 459   
 
    (i) A prescription for a supply of [auto–injectable ] EMERGENCY 1 
USE epinephrine from a licensed physician as provided in § 13 –7A–06 of this subtitle; and  2 
 
   (ii) A supply of [auto–injectable ] EMERGENCY USE  epinephrine 3 
from a licensed pharmacist or a licensed physician as provided in § 13 –7A–06 of this 4 
subtitle.  5 
 
  (2) Each participating facility shall store a supply of [auto–injectable ] 6 
EMERGENCY USE  epinephrine obtained under paragraph (1)(ii) of this subs ection:  7 
 
   (i) In accordance with the manufacturer’s instructions; and  8 
 
   (ii) In a location that is readily accessible to employees or affiliated 9 
individuals in an emergency situation.  10 
 
  (3) Each participating facility shall designate the employees who  are 11 
certificate holders or designated affiliated individuals who are certificate holders who will 12 
be responsible for the storage, maintenance, and control of the supply of [auto–injectable ] 13 
EMERGENCY USE  epinephrine.  14 
 
  (4) A participating facility may not obtain or store [auto–injectable ] 15 
EMERGENCY USE  epinephrine unless the participating facility has at least two employees 16 
or designated affiliated individuals who are certificate holders.  17 
 
  (5) Each participating facility s hall maintain a copy of the certificate issued 18 
to an employee or a designated affiliated individual under § 13 –7A–05 of this subtitle.  19 
 
13–7A–03. 20 
 
 (a) The Department shall:  21 
 
  (5) Develop a method by which certificate holders may submit a report to 22 
the De partment about each incident that occurred on the premises of a participating facility 23 
that involved the administration of [auto–injectable ] EMERGENCY USE  epinephrine by a 24 
certificate holder or an agent; and  25 
 
13–7A–06. 26 
 
 (a) (1) A physician licensed to pra ctice medicine in the State may prescribe 27 
[auto–injectable ] EMERGENCY USE  epinephrine in the name of a certificate holder.  28 
 
  (2) A pharmacist licensed to practice pharmacy in the State or a physician 29 
may dispense [auto–injectable ] EMERGENCY USE  epinephrin e under a prescription issued 30 
to a certificate holder.  31 
 
 (b) A certificate holder may:  32 
 SENATE BILL 459  11 
 
  
  (1) On presentment of a certificate, receive from any physician licensed to 1 
practice medicine in the State a prescription for [auto–injectable ] EMERGENCY USE  2 
epinephr ine and the necessary paraphernalia for the administration of [auto–injectable ] 3 
EMERGENCY USE  epinephrine; and  4 
 
  (2) Possess and store prescribed [auto–injectable ] EMERGENCY USE  5 
epinephrine and the necessary paraphernalia for the administration of [auto–injectable ] 6 
EMERGENCY USE  epinephrine.  7 
 
 (c) In an emergency situation when a physician or emergency medical services 8 
are not immediately available, a certificate holder or an agent may administer  9 
[auto–injectable ] EMERGENCY USE  epinephrine to an individua l who is experiencing or is 10 
believed in good faith by the certificate holder or agent to be experiencing anaphylaxis.  11 
 
13–7A–07. 12 
 
 (a) (1) Except as provided in paragraph (2) of this subsection, a cause of action 13 
may not arise against a certificate holder for any act or omission if the certificate holder or 14 
agent is acting in good faith while administering [auto–injectable ] EMERGENCY USE  15 
epinephrine to an individual who is experiencing or believed by the certificate holder or 16 
agent to be experiencing anaphylaxis except where the conduct of the certificate holder or 17 
agent amounts to gross negligence, willful or wanton misconduct, or intentional ly tortious 18 
conduct.  19 
 
  (2) The provisions of paragraph (1) of this subsection do not apply if a 20 
certificate holder or participating facility that makes available, or a certificate holder who 21 
administers, [auto–injectable ] EMERGENCY USE  epinephrine to an i ndividual who is 22 
experiencing or is believed by the certificate holder or participating facility to be 23 
experiencing anaphylaxis:  24 
 
   (i) Fails to follow standards and procedures for storage and 25 
administration of [auto–injectable ] EMERGENCY USE  epinephrine;  or 26 
 
   (ii) Administers [auto–injectable ] EMERGENCY USE  epinephrine 27 
that is beyond the manufacturer’s expiration date.  28 
 
 (b) (1) A cause of action may not arise against any physician for any act or 29 
omission if the physician in good faith prescribes or dis penses [auto–injectable ] 30 
EMERGENCY USE  epinephrine and the necessary paraphernalia for the administration of 31 
[auto–injectable ] EMERGENCY USE  epinephrine to a certificate holder or participating 32 
facility under this subtitle.  33 
 
  (2) A cause of action may not arise against any pharmacist for any act or 34 
omission if the pharmacist in good faith dispenses [auto–injectable ] EMERGENCY USE  35 
epinephrine and the necessary paraphernalia for the administration of [auto–injectable ] 36 
12 SENATE BILL 459   
 
 EMERGENCY USE  epinephrine to a certificate holder or a participating facility under this 1 
subtitle.  2 
 
13–7A–08. 3 
 
 (b) An individual may not be held civilly liable in any action arising from or in 4 
connection with the administration of [auto–injectable ] EMERGENCY USE  epineph rine by 5 
the individual solely because the individual did not possess a certificate issued under this 6 
subtitle.  7 
 
13–7A–09. 8 
 
 A certificate holder shall submit to the Department, in the manner required under § 9 
13–7A–03 of this subtitle, a report of each inci dent that occurred on the premises of a 10 
participating facility that involved the administration of [auto–injectable ] EMERGENCY 11 
USE epinephrine by a certificate holder or an agent.  12 
 
Article – Health Occupations  13 
 
14–5F–01. 14 
 
 (a) In this subtitle the followin g words have the meanings indicated.  15 
 
 [(c) “Auto –injectable epinephrine” means a portable, disposable drug delivery 16 
device that contains a premeasured single dose of epinephrine that is used to treat 17 
anaphylaxis in an emergency situation. ] 18 
 
 [(d)] (C) “Board” means the State Board of Physicians.  19 
 
 [(e)] (D) “Committee” means the Naturopathic Medicine Advisory Committee.  20 
 
 [(f)] (E) “Council” means the Naturopathic Doctors Formulary Council.  21 
 
 [(g)] (F) (1) “Device” means a device used in the diagnosis, treatment, or 22 
prevention of disease.  23 
 
  (2) “Device” does not include:  24 
 
   (i) Any surgical or dental instrument;  25 
 
   (ii) Any physical therapy equipment;  26 
 
   (iii) Any X –ray apparatus; or  27 
 
   (iv) Any component part or accessory of any of the items listed  in 28 
items (i) through (iii) of this paragraph.  29 
 SENATE BILL 459  13 
 
  
 (G) “EMERGENCY USE EPINEPH RINE” MEANS A PORTABLE , DISPOSABLE 1 
DRUG DELIVERY DEVICE  OR PRODUCT APPROVED BY THE FEDERAL FOOD AND 2 
DRUG ADMINISTRATION THAT C ONTAINS A PREMEASURE D SINGLE DOSE OF 3 
EPINEPHRINE THAT I S USED TO TREAT ANAP HYLAXIS IN AN EMERGE NCY SITUATION . 4 
 
14–5F–04.1.  5 
 
 (a) (1) There is a Naturopathic Doctors Formulary Council within the Board.  6 
 
 (d) (1) The formulary adopted by the Board shall include:  7 
 
   (i) Nonprescription drugs and devices;  8 
 
   (ii) Prescription oxygen and [auto–injectable ] EMERGENCY USE  9 
epinephrine; and  10 
 
   (iii) Prescription diaphragms and cervical caps for contraception.  11 
 
14–5F–14. 12 
 
 (a) A license authorizes a licensee, consistent with naturopathic education and 13 
training and c ompetence demonstrated by passing the naturopathic physician licensing 14 
examination, to:  15 
 
  (5) Administer [auto–injectable ] EMERGENCY USE  epinephrine;  16 
 
 SECTION 2. AND BE IT FURTHER ENACTED, That this Act shall take effect June 17 
1, 2025.  18 
 
 
 
 
Approved:  
________________________________ ________________________________ ________________   
           Governor.  
________________________________ ________________________________ ________________   
                 President of the Senate.  
________________________________ ________________________________ ________________   
         Speaker of the House of Delegates.  